Novavax Inc - Company Profile
Powered by 
All the data and insights you need on Novavax Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date Novavax Inc Strategy Report
- Understand Novavax Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Related keylists
The following section provides information on Novavax Inc’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into Novavax Inc's management and employees, unlock the full data with our company analytics monitoring tool.
Executives
James F. Young, Ph.D.
Chairman Executive BoardDr. James F. Young has been the Chairman of the company since 2011. Prior to this, he was the President of Research and Development at MedImmune. Mr. Young also served as a Director of Molecular Genetics Department at Smith Kline & French Laboratories.
John C. Jacobs
Chief Executive Officer; President; Director Executive BoardMr. John Jacobs has been the Chief Executive Officer and President and Director of the company since 2023. Prior to this he served as a s President, Chief Executive Officer and Director from June 2018 to 2023, and Executive Vice President and Chief Commercial Officer from October 2017 to June 2018 at Harmony Biosciences. Prior to this he served as Senior Vice President and General Manager of the Respiratory Business Unit, Senior Vice President of Commercial Operations in North America and General Manager of Teva in Canada.
Jim Kelly
Executive Vice President; Treasurer; Chief Financial Officer Senior ManagementMr. Jim Kelly has been the Executive Vice President, Chief Financial Officer and Treasurer of the company since 2021. Most recently he served as Chief Financial Officer at Supernus Pharmaceuticals.
John J. Trizzino
Chief Operating Officer; President Senior ManagementMr. John J. Trizzino has been the President and Chief Operating Officer of the company since 2023. Previously, he served as Executive Vice President, Chief Business Officer and Chief Commercial Officer of the company. Prior to this role, he served as Senior Vice President, Chief Business Officer and Chief Financial Officer of the company. Prior to this, he served as the Senior Vice President, Commercial Operations of the company. Mr. Trizzino also served as the Senior Vice President, Business Development and International and Government Alliances of Novavax, Chief Executive Officer of ImmunoVaccine. Inc, Vice President at Vaccine Franchise at Medimmune, LLC, Senior Vice President, Business Development at ID Biomedical, and Vice President, Business Development in the Medical Group of Henry Schein, Inc.
Rick Crowley
Executive Vice President; Chief Operating Officer Senior ManagementMr. Rick Crowley has been the Executive Vice President and the Chief Operations Officer of the company since 2020. Prior to this role, he served as Executive Vice President, Technical Operations for TerSera Pharmaceuticals. Previously, he served as Senior Vice President, Operations and Quality Assurance for Crealta Pharmaceuticals from 2014 to 2016. .
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer